A new approach for gene delivery into retinal bipolar cells
To date, various approaches have been used to restore some visual functions in affected patients, primarily human derived retinal organoids and gene therapies. First directly administered Adeno-associated virus (AAV) based gene therapy approved by U.S. Food and Drug Administration (FDA), Luxturna, significantly improved the vision of patients with retinal dystrophy at low light levels. Nevertheless, […]